{
    "title": "Jean Solomides : Physiatrons vs Cancer",
    "inventor_name": "Jean Solomides",
    "publication_year": null,
    "device_name": "Physiatrons (synthetic peroxidase preparations)",
    "goal": "Treat and cure cancer by selectively destroying cancer cells",
    "problem_addressed": "Cancerous tumors and malignant cells",
    "concept_summary": "Jean Solomides claimed that synthetic peroxidases (oxidation catalysts) and certain oil/aldehyde based formulations selectively bind to cancer cell membranes and oxidize them, leading to tumor regression. He also used iodized cod liver oil and aldehydes (hexanal, heptanal, octanal, citral) as topical or injectable treatments for various cancers and skin conditions.",
    "detailed_description": "Solomides discovered in 1947 that synthetic peroxidases could destroy cultures of tuberculous bacilli and cancer cells by oxidation, selectively fixing on their membranes. He prepared ointments and injections containing cod liver oil distillate, synthetic peroxidases, and aldehydes (hexanal, heptanal, octanal, citral) and reported anecdotal cures, such as his father's inoperable liver tumor disappearing within three weeks. He also marketed products like Gadistol (cod liver oil based) for eczema, skin cancers, and radiodermitis. The treatments were claimed to prevent tumor development, reduce suffering, and allow patients to resume normal activities, but they were never approved by regulatory agencies.",
    "principles": [
        "Selective oxidation of cancer cell membranes",
        "Catalytic activity of synthetic peroxidases",
        "Membrane-binding selectivity of peroxidase complexes",
        "Cytotoxic effects of aldehydes on tumor cells"
    ],
    "scientific_domains": [
        "Biochemistry",
        "Oncology",
        "Pharmacology"
    ],
    "mechanisms_of_action": [
        "Oxidative damage to tumor cell membranes via peroxidase activity",
        "Selective binding of peroxidase complexes to cancer cells",
        "Aldehyde-induced cytotoxicity and inflammation modulation"
    ],
    "materials": [
        "Synthetic peroxidase (oxidation catalyst)",
        "Cod liver oil (iodized distillate)",
        "Hexanal",
        "Heptanal",
        "Octanal",
        "Citral",
        "Geranyl",
        "Urethane"
    ],
    "energy_sources": [],
    "inputs": [
        "Patient tumor tissue or skin lesion",
        "Dosage of peroxidase solution or aldehyde ointment",
        "Cod liver oil preparation"
    ],
    "outputs": [
        "Tumor reduction or disappearance",
        "Cancer cell death",
        "Symptom relief (e.g., eczema improvement)"
    ],
    "claimed_performance": "Complete disappearance of an inoperable liver tumor in three weeks; cure of numerous skin cancers and eczema; reported remission of various internal cancers.",
    "experimental_evidence": "Anecdotal case reports (e.g., father's liver tumor, individual skin cancer cases) and limited publications in French medical journals; no peer-reviewed clinical trials or quantitative data presented.",
    "replication_status": null,
    "keywords": [
        "cancer therapy",
        "synthetic peroxidase",
        "physiatron",
        "cod liver oil",
        "aldehydes",
        "chemical oncology"
    ],
    "related_technologies": [
        "Chemotherapy",
        "Immunotherapy",
        "Topical dermatological treatments"
    ],
    "controversy_level": "high",
    "confidence_score": 0.4,
    "practicability_score": 0.3,
    "fringe_score": 0.8,
    "evidence_strength": 0.2,
    "risk_score": 0.5,
    "trl_estimate": 3,
    "source_urls": [
        "http://lucadeparis.free.fr/infosweb/solomides.htm",
        "https://fr.wikipedia.org/wiki/Jean_Solomid%C3%A8s"
    ],
    "organizations": [
        "Institut Pasteur",
        "CNRS",
        "Institut Gustave-Roussy"
    ],
    "applications": [
        "Cancer treatment",
        "Skin cancer therapy",
        "Eczema and dermatological conditions"
    ],
    "limitations": [
        "Lack of controlled clinical trials",
        "Unclear safety profile of synthetic peroxidases",
        "No regulatory approval (AMM) obtained",
        "Reliance on anecdotal evidence"
    ],
    "open_questions": [
        "What is the exact molecular mechanism of selective membrane binding?",
        "How does efficacy compare with standard chemotherapy?",
        "What are the long-term toxicological effects of repeated peroxidase exposure?"
    ],
    "red_flags": [
        "Claims of cure without quantitative data",
        "Legal disputes over illegal practice of medicine",
        "Potential for unverified toxicity"
    ],
    "evidence_quotes": [
        "He discovered in 1947 that synthetic peroxidases (oxidation catalysts) destroy, by oxidation, cultures of tuberculous bacilli, but also cancer cells by Selectively fixing on their membrane.",
        "He sends Famagusta iodized distillate of cod liver oil in solution giving advice for treatment and injection. Doctors are amazed to see the tumor disappear in three weeks.",
        "The cure of his father arouses negative reactions at the Institut Pasteur ... He was dismissed from the Institute at the end of 1949.",
        "He treats a neighbor with a stomach cancer, whom a surgeon, after opening, has closed again without operating because of the size of the tumor.",
        "Because of his successes, five to ten patients a day present themselves."
    ],
    "category": "Chemistry & Chemical Processes"
}